The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and tolerability of second-line intra-arterial 5FU or mitomycine C after intra-arterial oxaliplatin failure in patients with colorectal cancer and unresectable liver metastases.
 
Simon Pernot
Consulting or Advisory Role - Amgen; Merck; Sanofi
Travel, Accommodations, Expenses - Amgen; Merck
 
Guillaume Velut
No Relationships to Disclose
 
Hampig Raphael Kourie
No Relationships to Disclose
 
Gregory Amouyal
No Relationships to Disclose
 
Marc Sapoval
No Relationships to Disclose
 
Anne-Laure Pointet
No Relationships to Disclose
 
Bruno Landi
No Relationships to Disclose
 
Yosra Zaaimi
No Relationships to Disclose
 
Céline Lepère
No Relationships to Disclose
 
Olivier Pellerin
No Relationships to Disclose
 
Julien Taieb
No Relationships to Disclose